Shenzhen Weiguang Biological Products Co., Ltd. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was CNY 659.82 million compared to CNY 894.22 million a year ago. Revenue was CNY 667.93 million compared to CNY 907.43 million a year ago.

Net income was CNY 117.44 million compared to CNY 205.44 million a year ago. Basic earnings per share from continuing operations was CNY 0.5178 compared to CNY 0.9058 a year ago. Diluted earnings per share from continuing operations was CNY 0.5178 compared to CNY 0.9058 a year ago.